Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Regulation of the tumourigenic ability of glioblastoma stem-like cells
FY 2012-13
Summary
Tumours of glial cell origin (gliomas) are among the most malignant and deadly cancers in the adult human brain and include grade II astrocytoma, grade III anaplastic astrocytoma, and the most common and malignant form, glioblastoma (grade IV). Adult gliomas are quite common with more than 15,000 primary cases diagnosed annually in North America. The majority of these tumours grow rapidly and are widely invasive, resulting in poor patient prognosis. In particular, glioblastoma patients have an average survival time of only 15 months due to the tumour's aggressive and invasive nature that the current advances in neurosurgery, radiation therapy and chemotherapy can only temporarily contain. Perhaps the most devastating part of the disease is its recurrent nature; the tumour often recurs within 7 months after surgery. It is hypothesized that the recurrence, and in part occurrence, of glioblastoma is due to a population of cells in the tumour with stem cell-like properties. The main goal of the proposed study is to clarify the molecular events that occur during glioblastoma initiation, progression, and recurrence by focusing on this highly potent cell population which therapy has not yet managed to conquer. In this regard, our laboratory has combined the analysis of surgical glioblastoma specimens with primary tissue culture of glioblastoma-derived cells with stem-like and tumour forming ability. Specifically, we seek to characterize molecular mechanisms important for gene regulation events underlying the self-renewal and tumourigenic potential of glioblastoma stem-like cells. It is anticipated that understanding what has gone awry in these glioblastoma cells at a molecular level will provide important new insights into the pathobiology of this deadly brain cancer. Moreover, we hope that this information will allow us to design new approaches aimed at providing previously unavailable therapeutic options for glioblastoma.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
283849
Name
Dali Rola
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Regulation of the tumourigenic ability of glioblastoma stem-like cells
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Brain Cancer; Cancer Stem Cells; High Throughput Sequencing; Transcriptional Networks
Abstract
Tumours of glial cell origin (gliomas) are among the most malignant and deadly cancers in the adult human brain and include grade II astrocytoma, grade III anaplastic astrocytoma, and the most common and malignant form, glioblastoma (grade IV). Adult gliomas are quite common with more than 15,000 primary cases diagnosed annually in North America. The majority of these tumours grow rapidly and are widely invasive, resulting in poor patient prognosis. In particular, glioblastoma patients have an average survival time of only 15 months due to the tumour's aggressive and invasive nature that the current advances in neurosurgery, radiation therapy and chemotherapy can only temporarily contain. Perhaps the most devastating part of the disease is its recurrent nature; the tumour often recurs within 7 months after surgery. It is hypothesized that the recurrence, and in part occurrence, of glioblastoma is due to a population of cells in the tumour with stem cell-like properties. The main goal of the proposed study is to clarify the molecular events that occur during glioblastoma initiation, progression, and recurrence by focusing on this highly potent cell population which therapy has not yet managed to conquer. In this regard, our laboratory has combined the analysis of surgical glioblastoma specimens with primary tissue culture of glioblastoma-derived cells with stem-like and tumour forming ability. Specifically, we seek to characterize molecular mechanisms important for gene regulation events underlying the self-renewal and tumourigenic potential of glioblastoma stem-like cells. It is anticipated that understanding what has gone awry in these glioblastoma cells at a molecular level will provide important new insights into the pathobiology of this deadly brain cancer. Moreover, we hope that this information will allow us to design new approaches aimed at providing previously unavailable therapeutic options for glioblastoma.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dali, Rola
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~